FIELD: medicine.
SUBSTANCE: invention can be used for diagnosing secondary glaucoma is the patients suffering vascular corneal leukoma. A method involves an optical coherent tomography of an anterior eye segment (OCT AES), an ultrasonic biomicroscopy (UBM) followed by measuring a critical frequency of flashing phosphene extinguishing (CFPE) with a echo biometry. If the OCT AES and UBM findings show the presence of iris-corneal adhesions with a closed angle of the anterior chamber through one or more quadrants, the CFPE values are less than 40 Hz, and the echo biometry shows an increase of an anterio-posterior axis by more than 1.0 mm for one year, secondary glaucoma is diagnosed.
EFFECT: method provides the accurate and objective diagnosis in the patients of the given group with the poorly transparent cornea having irregular curvature, shape and turgor.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SURGICAL MANAGEMENT OF SECONDARY GLAUCOMA IN PATIENTS WITH BURN AND TERMINAL DYSTROPHIC LEUKOMA | 2024 |
|
RU2824291C1 |
METHOD OF COMBINED TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA AT EARLY STAGES | 2019 |
|
RU2708045C1 |
METHOD OF COMBINED TREATMENT OF SEVERE FORMS OF SECONDARY NEOVASCULAR GLAUCOMA | 2019 |
|
RU2708059C1 |
METHOD OF CLINICAL ASSESSMENT OF IRIDOLENTICULAR CONTACT | 2016 |
|
RU2629339C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING LOW-PRESSURE GLAUCOMA | 2023 |
|
RU2823133C1 |
METHOD OF DIAGNOSING CHOROIDAL EFFUSION AFTER FILTER-TYPE OPERATIONS | 2022 |
|
RU2813151C2 |
METHOD FOR KERATOPROSTHESIS OF VASCULAR COMPLICATED LEUKOMAS OF CATEGORY 4 AND 5 | 2013 |
|
RU2523342C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF PRIMARY CLOSED ANGLE GLAUCOMA | 2020 |
|
RU2743329C1 |
METHOD OF NAVIGATION LASER TREATMENT OF RHEGMATOGENOUS PERIPHERAL RETINAL DEGENERATIONS (EMBODIMENTS) | 2023 |
|
RU2812202C1 |
METHOD FOR DETERMINING INDICATIONS TO REMOVAL OF PRESBYOPIC LENS WITH INTRAOCULAR LENS IMPLANTATION IN GLAUCOMA | 2015 |
|
RU2594069C1 |
Authors
Dates
2014-12-27—Published
2013-11-29—Filed